Mouse 4T1 breast tumor model.
Pulaski BA, Ostrand-Rosenberg S.
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2. doi: 10.1002/0471142735.im2002s39.
Glucocorticoids promote breast cancer metastasis.
Obradović MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM, Münst S, Okamoto R, Kohler H, Schmidt A, Bentires-Alj M.
Nature. 2019 Mar;567(7749):540-544. doi: 10.1038/s41586-019-1019-4. Epub 2019 Mar 13.
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer.
Pei G, Min J, Rajapakshe KI, Branchi V, Liu Y, Selvanesan BC, Thege F, Sadeghian D, Zhang D, Cho KS, Chu Y, Dai E, Han G, Li M, Yee C, Takahashi K, Garg B, Tiriac H, Bernard V, Semaan A, Grem JL, Caffrey TC, Burks JK, Lowy AM, Aguirre AJ, Grandgenett PM, Hollingsworth MA, Guerrero PA, Wang L, Maitra A.
Nature. 2025 Jun;642(8066):212-221. doi: 10.1038/s41586-025-08927-x. Epub 2025 Apr 23.
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document.
Lievens Y, Guckenberger M, Gomez D, Hoyer M, Iyengar P, Kindts I, Méndez Romero A, Nevens D, Palma D, Park C, Ricardi U, Scorsetti M, Yu J, Woodward WA.
Radiother Oncol. 2020 Jul;148:157-166. doi: 10.1016/j.radonc.2020.04.003. Epub 2020 Apr 22.
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C.
N Engl J Med. 2012 Mar 8;366(10):883-892. doi: 10.1056/NEJMoa1113205.
Decoding the interplay between genetic and non-genetic drivers of metastasis.
Karras P, Black JRM, McGranahan N, Marine JC.
Nature. 2024 May;629(8012):543-554. doi: 10.1038/s41586-024-07302-6. Epub 2024 May 15.
CECR2 drives breast cancer metastasis by promoting NF-kappaB signaling and macrophage-mediated immune suppression.
Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, Zhang Y, An Y, Chen JF, Chan LH, Aoshima A, Lang SM, Tang Z, Che X, Li Y, Rutter SJ, Bossuyt V, Chen X, Morrow JS, Pusztai L, Rimm DL, Yin M, Yan Q.
Sci Transl Med. 2022 Feb 2;14(630):eabf5473. doi: 10.1126/scitranslmed.abf5473. Epub 2022 Feb 2.
CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
Wang YN, Zeng ZL, Lu J, Wang Y, Liu ZX, He MM, Zhao Q, Wang ZX, Li T, Lu YX, Wu QN, Yu K, Wang F, Pu HY, Li B, Jia WH, Shi M, Xie D, Kang TB, Huang P, Ju HQ, Xu RH.
Oncogene. 2018 Nov;37(46):6025-6040. doi: 10.1038/s41388-018-0384-z. Epub 2018 Jul 11.
Metabolic control of cancer metastasis: role of amino acids at secondary organ sites.
Karno B, Edwards DN, Chen J.
Oncogene. 2023 Nov;42(47):3447-3456. doi: 10.1038/s41388-023-02868-3. Epub 2023 Oct 18.
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R, Zhu Y, Liu X, Liao X, He J, Niu L.
BMC Cancer. 2019 Nov 12;19(1):1091. doi: 10.1186/s12885-019-6311-z.
